Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 1/2024

04-07-2023 | Correction

Correction to: Basic fibroblast growth factor alleviates metabolic abnormalities in the heart of streptozotocin-induced diabetic rats

Authors: Yinli Huang, Wei Dong, Minjie Lin, Hongchang Gao, Hong Zheng

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2024

Login to get access

Excerpt

Correction to: International Journal of Diabetes in Developing Countries (January–February 2023) 43(1):163–170 …
Metadata
Title
Correction to: Basic fibroblast growth factor alleviates metabolic abnormalities in the heart of streptozotocin-induced diabetic rats
Authors
Yinli Huang
Wei Dong
Minjie Lin
Hongchang Gao
Hong Zheng
Publication date
04-07-2023
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2024
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-023-01219-y

Other articles of this Issue 1/2024

International Journal of Diabetes in Developing Countries 1/2024 Go to the issue

Original Article

Bone mineral density and its predictors in a cohort of adults with type 1 diabetes attending a tertiary care institute in North India

Original Article

The association between thyroid hormone changes within the normal range and bone mineral density in patients with type 2 diabetes mellitus

Original Article

Free T4 is associated with exenatide-related weight loss in patients with type 2 diabetes mellitus and obesity

Original Article

Changes in HbA1c values of patients with type 2 diabetes mellitus during the pandemic period and their relationship to food literacy

Original Article

Lack of Faecalibacterium prausnitzii and Bifidobacterium is associated with a higher risk of metabolic associated fatty liver disease in young-onset type 2 diabetes

Original Article

The importance of active B12 (holotranscobalamin) measurement in the diagnosis of vitamin B12 deficiency in type 2 DM patients using metformin
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits